Representativeness of Study Participants from Phase I Study of Mtorc1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with Mtor/akt/pi3k Pathway Alterations and Advanced Solid Malignancies
openalex（2024）
Key words
PI3K/AKT pathway
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined